Q32 Bio (QTTB) Net Cash Flow (2017 - 2026)

Q32 Bio's Net Cash Flow history runs 10 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• On a quarterly basis, Net Cash Flow rose 119.66% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was -$14.7 million, a 70.55% increase from a year earlier, with the FY2025 full-year figure at -$29.7 million, down 162.66% from the prior year.
• Net Cash Flow advanced to $2.5 million in Q1 2026 per QTTB's latest filing, from -$742000.0 in the prior quarter.
• Across five years, Net Cash Flow topped out at $138.1 million in Q1 2022 and bottomed at -$133.0 million in Q3 2022.
• The 5-year median for Net Cash Flow is -$10.6 million (2023), against an average of -$4.4 million.
• Across the five-year window, Net Cash Flow plunged 707.0% in 2022 and jumped 779.9% in 2024, its largest moves.
• Year by year, Net Cash Flow stood at -$9.2 million in 2022, then dropped by 15.94% to -$10.6 million in 2023, then fell by 4.46% to -$11.1 million in 2024, then soared by 93.32% to -$742000.0 in 2025, then jumped by 430.73% to $2.5 million in 2026.
• Per Business Quant, the three latest QTTB Net Cash Flow figures stand at $2.5 million (Q1 2026), -$742000.0 (Q4 2025), and -$5.8 million (Q3 2025).